KODIAK SCIENCES INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.355 USD | +2.29% |
|
-1.17% | +11.18% |
| 04/04 | UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating | MT |
| 01/04 | Barclays Raises Price Target on Kodiak Sciences to $3 From $2, Maintains Underweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KODIAK SCIENCES INC. | Bio Therapeutic Drugs | +3.05% | -1.17% | +11.18% | -25.55% | -53.70% | 172M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- KOD Stock
- Charts Kodiak Sciences Inc.
- Comparison Chart
